» Articles » PMID: 29159606

Preoperative Ga-DOTA-Somatostatin Analog-PET/CT Hybrid Imaging Increases Detection Rate of Intra-abdominal Small Intestinal Neuroendocrine Tumor Lesions

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2017 Nov 22
PMID 29159606
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Small intestinal neuroendocrine tumors (SI-NETs) are the most common form of neoplasm in the small bowel. Radiological identification of primary tumors (PT), which may be multiple, is difficult, and therefore palpation of the entire small bowel is routinely performed during laparotomy. The aim was to determine detection rates of PT and peritoneal carcinomatosis (PC) with Ga-DOTATOC/TATE-PET/CT in comparison with i.v. contrast-enhanced computed tomography (CE-CT) and thus to clarify whether modern functional imaging can mitigate the need for palpation of bowel during surgery enabling oncologically adequate laparoscopic resection.

Methods: A total of 28 patients with SI-NET who preoperatively underwent both Ga-DOTATOC/TATE-PET/CT and CE-CT were included. The detection rates of PT and PC for PET/CT and CE-CT were compared to the findings in the surgical and histopathological reports. Appropriate statistical tests were used, and significance was set to p < 0.05.

Results: Out of 82 PT, 43 PT were not detected by any imaging modality. More PT lesions were detected with PET/CT (n = 39 [47.5%]) than with CE-CT (n = 10 [12.2%], p < 0.001). Also, PET/CT identified significantly more PC lesions than CE-CT (78 and 38%, p = 0.004, respectively).

Conclusion: PET/CT detected more PT and PC lesions than CE-CT. Some PTs and PC lesions were only detected by one of the modalities, and CT performed in conjunction with PET/CT should therefore be performed as a fully diagnostic CE-CT for optimal results. Palpation of the small bowel remains crucial during surgery in these patients because several PTs escaped detection by both PET/CT and CE-CT.

Citing Articles

Portuguese Pancreatic Club Perspectives on Pancreatic Neuroendocrine Neoplasms: Diagnosis and Staging, Associated Genetic Syndromes and Particularities of Their Clinical Approach.

Ferreira-Silva J, Meireles S, Falconi M, Fernandes A, Vilas-Boas F, Bispo M GE Port J Gastroenterol. 2024; 31(3):153-164.

PMID: 38836119 PMC: 11149993. DOI: 10.1159/000534641.


Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study.

Li X, Fan Y, Tong J, Lou M Front Endocrinol (Lausanne). 2024; 15:1264952.

PMID: 38449852 PMC: 10916283. DOI: 10.3389/fendo.2024.1264952.


Multimodality imaging features of small bowel cancers complicating Crohn's disease: a pictorial review.

Paparo F, Panvini N, Montale A, Pigati M, Marinaro E, Melani E Abdom Radiol (NY). 2024; 49(6):2083-2097.

PMID: 38441632 DOI: 10.1007/s00261-024-04201-2.


Surgery as a Principle and Technical Consideration for Primary Tumor Resection of Small Bowel Neuroendocrine Tumors.

Soreide K, Stattner S, Hallet J Ann Surg Oncol. 2023; 31(2):1125-1137.

PMID: 38006527 PMC: 10761444. DOI: 10.1245/s10434-023-14610-0.


The Driver Role of Pathologists in Endocrine Oncology: What Clinicians Seek in Pathology Reports.

Ezzat S, de Herder W, Volante M, Grossman A Endocr Pathol. 2023; 34(4):437-454.

PMID: 37166678 PMC: 10733199. DOI: 10.1007/s12022-023-09768-y.


References
1.
Sundin A, Arnold R, Baudin E, Cwikla J, Eriksson B, Fanti S . ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging. Neuroendocrinology. 2017; 105(3):212-244. DOI: 10.1159/000471879. View

2.
Pavel M, Baudin E, Couvelard A, Krenning E, Oberg K, Steinmuller T . ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 2012; 95(2):157-76. DOI: 10.1159/000335597. View

3.
Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder W . TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006; 449(4):395-401. PMC: 1888719. DOI: 10.1007/s00428-006-0250-1. View

4.
Rindi G, Wiedenmann B . Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol. 2011; 8(1):54-64. DOI: 10.1038/nrendo.2011.120. View

5.
Poeppel T, Binse I, Petersenn S, Lahner H, Schott M, Antoch G . Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors. Recent Results Cancer Res. 2012; 194:353-71. DOI: 10.1007/978-3-642-27994-2_18. View